Catarina Marchon da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Catarina Marchon da Silva has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Allyne Queiroz Carneiro Cagnacci
Department of Oncology Oncology Center, Hospital Alemão Oswaldo Cruz São Paulo São Paulo Brazil
1 shared publication - Ana Carolina Ribeiro Chaves de Gouvêa
Centro de Oncologia e Doenças Autoimune (COE), São Jose dos Campos, SP, Brazil
1 shared publication Andrea Santos Galvão
1 shared publication- Bernardino Alves Ferreira Neto1 shared publication
- Carla Ismael1 shared publication
- Christian Domenge
Department of Oncohematology, Hospital 9 de Julho/ Instituto Oncológico de Juiz de Fora, Juiz de Fora, MG, Brazil
1 shared publication
Latest Publications
- Open Access
- 21 July 2022
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Factors related to survival in Intensive Care Unit patients with Covid-19: a study from a single center in Brazil
Introduction: Analysis of the outcome of 268 ICU patients in a single-center, as well the impact of viral infection on patients with preexisting medical conditions and how these factors affected survival and hospital stay. Methodology: Patients admitted to the ICU from March-August, 2020 were retrospectively analyzed under the same protocol at Hospital Alemão Oswaldo Cruz, São Paulo, Brazil. Several factors were considered and the results were presented using 95% confidence intervals. For statistical significance, p <0.05 was adopted. Results: Patient median age was 72 years, 64,2 years for discharged patients and 79.9 years for those deceased (p<0.001). The most common comorbidities were: systemic arterial hypertension, diabetes, thyroid disease, cardiovascular and kidney disease. Predictors of survival through univariate analysis: myalgia (p=0.001), cerebrovascular disease (p=0.002), COPD (p=0.003), dementia (p=0.000), mechanical ventilation (p=0.000), dialysis (0.000), vasopressor use (0.000), SAPS3 (0.000), lymphopenia (p=0.004), elevated D-dimer (P=0.011), time in ICU before tracheostomy (p=0.002), and performing a tracheostomy (p=0.000). The independent predictors of mortality were: advanced age (p=0.003) and tracheostomy performed in ICU (p=0.002). Discussion: COVID-19 affects usually older adults, where there already is a higher fatality rate. Acute respiratory distress syndrome is the primary cause of death and <5% of patients were reported as experiencing co-infection at admission. Conclusion: age, vasopressor use in patients with tracheostomy, and systemic coronary disease, heart failure, neoplasia, and COPD, were found to be significantly associated with COVID-19 severity.
- 21 July 2022
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Open AccessFactors related to survival in Intensive Care Unit patients with Covid-19: a study from a single center in Brazil
Introduction: Analysis of the outcome of 268 ICU patients in a single-center, as well the impact of viral infection on patients with preexisting medical conditions and how these factors affected survival and hospital stay. Methodology: Patients admitted to the ICU from March-August, 2020 were retrospectively analyzed under the same protocol at Hospital Alemão Oswaldo Cruz, São Paulo, Brazil. Several factors were considered and the results were presented using 95% confidence intervals. For statistical significance, p <0.05 was adopted. Results: Patient median age was 72 years, 64,2 years for discharged patients and 79.9 years for those deceased (p<0.001). The most common comorbidities were: systemic arterial hypertension, diabetes, thyroid disease, cardiovascular and kidney disease. Predictors of survival through univariate analysis: myalgia (p=0.001), cerebrovascular disease (p=0.002), COPD (p=0.003), dementia (p=0.000), mechanical ventilation (p=0.000), dialysis (0.000), vasopressor use (0.000), SAPS3 (0.000), lymphopenia (p=0.004), elevated D-dimer (P=0.011), time in ICU before tracheostomy (p=0.002), and performing a tracheostomy (p=0.000). The independent predictors of mortality were: advanced age (p=0.003) and tracheostomy performed in ICU (p=0.002). Discussion: COVID-19 affects usually older adults, where there already is a higher fatality rate. Acute respiratory distress syndrome is the primary cause of death and <5% of patients were reported as experiencing co-infection at admission. Conclusion: age, vasopressor use in patients with tracheostomy, and systemic coronary disease, heart failure, neoplasia, and COPD, were found to be significantly associated with COVID-19 severity.
- Open Access
- 2 May 2020
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Universal Screening of SARS-CoV-2 of Oncology Healthcare Workers — a Brazilian experience
The first confirmed case of coronavirus disease 2019 (COVID-19) in Brazil and Latin America was reported on February 26, 2020, in São Paulo. The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has placed unprecedented strain on health-care services worldwide. Asymptomatic health-care workers (HCW) are a potential source of SARS-CoV-2 transmission, especially to immunocompromised Oncology patients. Screening of these HCWs may help contain transmission and isolate only those who require it. At Centro de Terapia Oncológica (CTO), an Oncology clinic in Petrópolis, RJ —Brazil, all HCWs were screened for SARS-CoV-2 in order to isolate those who were asymptomatic/symptomatic and positive for the virus. They were all tested through IgM/IgG rapid testing and those who had symptoms were also tested with nasopharyngeal swabs for reverse transcription polymerase chain reaction (RT-PCR) tests besides IgM/IgG reactivity. Amongst the 60 tested employees, 4 were positive for SARS-CoV-2 and were isolated. This method may be useful for health-care services to detect asymptomatic HCW and maintain workers’ and patients’ health, as transmission probability could be reduced while avoiding becoming short-staffed during this time of crisis.
- 2 May 2020
- Published by FapUNIFESP (SciELO) in SciELO Preprints
Open AccessUniversal Screening of SARS-CoV-2 of Oncology Healthcare Workers — a Brazilian experience
The first confirmed case of coronavirus disease 2019 (COVID-19) in Brazil and Latin America was reported on February 26, 2020, in São Paulo. The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has placed unprecedented strain on health-care services worldwide. Asymptomatic health-care workers (HCW) are a potential source of SARS-CoV-2 transmission, especially to immunocompromised Oncology patients. Screening of these HCWs may help contain transmission and isolate only those who require it. At Centro de Terapia Oncológica (CTO), an Oncology clinic in Petrópolis, RJ —Brazil, all HCWs were screened for SARS-CoV-2 in order to isolate those who were asymptomatic/symptomatic and positive for the virus. They were all tested through IgM/IgG rapid testing and those who had symptoms were also tested with nasopharyngeal swabs for reverse transcription polymerase chain reaction (RT-PCR) tests besides IgM/IgG reactivity. Amongst the 60 tested employees, 4 were positive for SARS-CoV-2 and were isolated. This method may be useful for health-care services to detect asymptomatic HCW and maintain workers’ and patients’ health, as transmission probability could be reduced while avoiding becoming short-staffed during this time of crisis.
- Open Access
- 21 January 2020
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 14, 1002
VUS-type alteration in POLD1 and microsatellite instability in a metastatic luminal B breast cancer patient
VUS-type alteration in POLD1 and microsatellite instability in a metastatic luminal B breast cancer patient Catarina Marchon da Silva1, Denis Shimb
- 21 January 2020
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 14, 1002
Open AccessVUS-type alteration in POLD1 and microsatellite instability in a metastatic luminal B breast cancer patient
VUS-type alteration in POLD1 and microsatellite instability in a metastatic luminal B breast cancer patient Catarina Marchon da Silva1, Denis Shimb